Skip to content

Blog

Enclomiphene, an antagonist of the oestrogen receptor, is used to treat men’s low testosterone levels

Overview   Repros Therapeutics Inc. is at the forefront of the development of enclomiphene (Androxal), a non-steroidal oestrogen receptor antagonist that has the potential to drastically change the treatment of secondary hypogonadism. Males with secondary hypogonadism may find relief from… Read More »Enclomiphene, an antagonist of the oestrogen receptor, is used to treat men’s low testosterone levels